Alerts will be sent to your verified email
Verify Email
PARNAXLAB
|
Parnax Lab
|
Bal Pharma
|
Tyche Inds
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
6.88 % | 1.96 % | 14.86 % |
|
5yr average Equity Multiplier
|
2.94 | 4.59 | 1.18 |
|
5yr Average Asset Turnover Ratio
|
0.99 | 0.98 | 0.6 |
|
5yr Avg Net Profit Margin
|
2.37 % | -0.04 % | 20.15 % |
|
Price to Book
|
1.73 | 1.82 | 1.01 |
|
P/E
|
13.36 | 19.7 | 11.42 |
|
5yr Avg Cash Conversion Cycle
|
42.8 Days | 41.77 Days | 86.71 Days |
|
Inventory Days
|
42.33 Days | 106.16 Days | 61.45 Days |
|
Days Receivable
|
58.46 Days | 104.16 Days | 108.17 Days |
|
Days Payable
|
69.32 Days | 132.37 Days | 93.08 Days |
|
5yr Average Interest Coverage Ratio
|
2.32 | 1.22 | 2385.83 |
|
5yr Avg ROCE
|
15.17 % | 15.4 % | 19.65 % |
|
5yr Avg Operating Profit Margin
|
11.62 % | 7.79 % | 23.57 % |
|
5 yr average Debt to Equity
|
1.28 | 2.03 | 0.0 |
|
5yr CAGR Net Profit
|
n/a | n/a | -6.96 % |
|
5yr Average Return on Assets
|
2.67 % | 0.43 % | 12.43 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
72.3 % | 50.86 % | 61.97 % |
|
Share Pledged by Promoters
|
9.41 % | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
4.72 % | -1.14 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Parnax Lab
|
Bal Pharma
|
Tyche Inds
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|